tropion-pantumor01: datopotamab deruxtecan in advanced her2 breast cancer
Published 2 years ago • 1.1K plays • Length 1:13Download video MP4
Download video MP3
Similar videos
-
3:02
pros from tropion-breast01: datopotamab deruxtecan in hr /her2- breast cancer
-
0:48
tropion-pantumor03: datopotamab deruxtecan in advanced solid tumors
-
1:36
efficacy of datopotamab deruxtecan, a trop2 adc, in ansclc
-
1:37
tropion-lung01 & tropion-lung05: datopotamab deruxtecan for nsclc
-
1:16
ongoing studies for datopotamab deruxtecan in nsclc
-
3:22
begonia: datopotamab deruxtecan and durvalumab in metastatic triple-negative breast cancer
-
1:24
begonia: durvalumab dato-dxd in advanced tnbc
-
1:23
antibody-drug conjugates for the treatment of breast cancer
-
1:30
begonia: durvalumab combinations in advanced tnbc
-
3:03
phase ii trial of patritumab deruxtecan in metastatic breast cancer
-
1:35
advances in novel adcs for her2-expressing breast cancer
-
0:48
highlights from esmo: destiny-breast03
-
8:53
interim results from destiny-lung01: t-dxd in her2-overexpressing nsclc
-
4:24
zenith20-4: efficacy & safety of poziotinib in treatment-naïve nsclc with her2 exon 20 mutations
-
1:25
dato-dxd: a new adc on the block
-
1:02:54
drs. johnson, levy, & yu discuss the latest lung cancer updates from #wclc21: https://bit.ly/3goriyo
-
2:24
ds-8201 pembro in patients her2 breast and nsclc
-
1:08
destiny-breast02: t-dxd in her2 metastatic breast cancer previously treated with t-dm1
-
1:20
updated results of destiny-breast03: t-dxd vs t-dm1 in metastatic her2 breast cancer